Magellan BioScience Group, Inc. provides sources of microbial extracts for drug discovery, agrochemical, enzyme, and specialty chemical research. Our field collection of over 10,000 marine microbes contains countless chemically diverse and unique compounds. Magellan's business strategy is to develop collaborations with research companies and academic centers. Natural Product Drug Discovery from marine microbes (bacteria, fungi, etc.), and from macroorganisms. Capable of isolations, fractionations, duiscovery, screening, small molecule isolation and development services. In 2009, the firm sold their life science tools business to Dionex Corporation
